DOI: 10.22270/jmpas.V10I6.2152
VOLUME - 10 ISSUE - 6 NOVEMBER-DECEMBER 2021
Barrawaz Aateka Yahya*, Abubakar Salam Bawazir, Sana Saffiruddin Shaikh, Mohammad Hasan Dehghan, Mohammed Abdul Jalil
Y. B. Chavan College of Pharmacy, Aurangabad, Maharashtra. India
ABSTRACT
Abiraterone acetate is a steroidal progesterone derivative that inhibits the enzymes CYP17A1, CYP11B1, and the androgen receptor antagonist. It is clinically used in adrenal, testicular, and prostatic cancer. Abiraterone has limited use, due to poor water solubility and low oral bioavailability (
Keywords:
Abiraterone acetate, ?-cyclodextrin nano sponges, Solubility, bioavailability